Antibodies

Antibodies

_arrow-up-right Myasthenia gravis., _arrow-up-right Goodpasture syndrome., _arrow-up-right SLE., _arrow-up-right Limited scleroderma (CREST syndrome)., _arrow-up-right Pemphigus vulgaris., _arrow-up-right Type 1 diabetes mellitus., _arrow-up-right Bullous pemphigoid., [](Anti-histidyl tRNA synthetase (eg, anti-Jo-1), anti-SRP, antihelicase (anti-Mi-2)) Polymyositis, dermatomyositis., [](Antimicrosomal, antithyroglobulin, anti-thyroid peroxidase) Hashimoto thyroiditis., _arrow-up-right 1° biliary cirrhosis., _arrow-up-right Pernicious anemia., _arrow-up-right 1° membranous nephropathy., _arrow-up-right Scleroderma (diffuse)., _arrow-up-right Autoimmune hepatitis type 1., [](Anti-SSA, anti-SSB (anti-Ro, anti-La)) Sjögren syndrome., [](Anti-TSH receptor) Graves disease., _arrow-up-right Lambert-Eaton myasthenic syndrome., _arrow-up-right Celiac disease., _arrow-up-right Microscopic polyangiitis, eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome), ulcerative colitis., _arrow-up-right Granulomatosis with polyangiitis (Wegener)., [](Rheumatoid factor (IgM antibody against IgG Fc region), anti-CCP (more specific))Rheumatoid arthritis., [](Antinuclear (ANA)) Nonspecific screening antibody, often associated with SLE., _arrow-up-right Drug-induced lupus., [_](Anti-U1 RNP (ribonucleoprotein)) Mixed connective tissue disease.,

Chromosome Disorders

_arrow-up-rightvon Hippel-Lindau disease, renal cell carcinoma., _arrow-up-rightADPKD (PKD2), achondroplasia, Huntington disease., _arrow-up-rightCri-du-chat syndrome, familial adenomatous polyposis., _arrow-up-rightHemochromatosis (HFE)., _arrow-up-rightWilliams syndrome, cystic brosis., _arrow-up-rightFriedreich ataxia., _arrow-up-rightWilms tumor, β-globin gene defects (eg, sickle cell disease, β-thalassemia,MEN1)., _arrow-up-rightPatau syndrome, Wilson disease, retinoblastoma (RB1), BRCA2., _arrow-up-rightPrader-Willi syndrome, Angelman syndrome, Marfan syndrome., _arrow-up-rightADPKD (PKD1), α-globin gene defects (eg, α-thalassemia)., _arrow-up-rightNeuro bromatosis type 1, BRCA1, p53., _arrow-up-rightEdwards syndrome., _arrow-up-rightDown syndrome., _arrow-up-rightNeuro bromatosis type 2, DiGeorge syndrome (22q11)., _arrow-up-rightFragile X syndrome, X-linked agammaglobulinemia, Klinefelter syndrome (XXY).,

Vitamins

_arrow-up-rightBiotin.,

Vaccines

_arrow-up-right..

_arrow-up-right..

Recombinant Cytokines

_arrow-up-right (G-CSF) Recovery of bone marrow and WBC counts bygranulocyte stimulation.,

_arrow-up-right (GM-CSF) Recovery of bone marrow and WBC counts bygranulocyte and monocyte stimulation.,

_arrow-up-right thrombopoietin analog.,

_arrow-up-rightthrombopoietin receptor agonist.,

_arrow-up-rightIL-11.,

_arrow-up-rightCD25, Multiple sclerosis treatment.,

_arrow-up-rightComplement C5, PNH.,

_arrow-up-righta4-integrin, MS/Crohn.,

_arrow-up-rightIL12, 23. Psoriasis.,

Repro drugs

_arrow-up-rightGnRH analog.,

_arrow-up-rightEstrogen antagonist at breast, agonist at bone/uterus.,

_arrow-up-rightEstrogen antagonist at breast, uterus. Agonist at bone.,

_arrow-up-rightaromatase inhibitors, used for ER positive breast cancer.,

_arrow-up-rightsynthetic androgen, partial agonist at androgen receptors. Inhibit FSH and LH production by the anterior pituitary (negative feedback). It is FDA-approved to treat women with endometriosis-related pain; however, it is rarely used due to its adverse effects (hirsutism, acne, hepatotoxicity, etc.).,

_arrow-up-rightandrogen receptor competitive inhibitor. Used for prostate cancer.,

Last updated